NL-OMON38394CompletedNot Applicable
Continuation of the Doetinchem Cohort Study - Doetinchem Cohort Study
RIVM0 sites4,500 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 4,500
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Being a participant of an earlier round of the Doetinchem Cohort Study. 20 years ago it was a random sample of the population in Doetinchem.
Exclusion Criteria
- •Not wanting to participate anymore as said during an earlier round.
Investigators
Similar Trials
Recruiting
Phase 1
The development of exosome monitoring marker in pancreatic cancerpancreatic cancer, pancreatic benign disease (chronic pancreatitis, IPMN)pancreatic cancer, exosomeD010190, D050500, D000077779JPRN-jRCT1030230227ana Shimamoto280
Completed
Unknown
An extended study in the clinical evaluation of direct oral anticoagulantsAtrial fibrillationJPRN-UMIN000050585Japan Science and Technology Agency6,900
Completed
Not Applicable
ationwide Cohort study on the development of diagnosis and treatment of pheochromocytoma in JapaPheochromocytomaJPRN-UMIN000004151Ministry of Health, Labour and Welfare , The Japan Endocrine Society2,500
Not yet recruiting
Not Applicable
Diagnostic accuracy of combination of HEART Pathway and 0- hour/1-hour hs-cTnT protocol for the prediction of MACE among acute chest paiCTRI/2023/06/053367JAMEEL A
Not yet recruiting
Not Applicable
Observational prospective cohort study of the niche with a long term follow up.iche Caesarean scar defect.NL-OMON20181Vu medical center250